1.52
price down icon5.00%   -0.08
pre-market  Pre-mercato:  1.53   0.01   +0.66%
loading

Opko Health Inc Borsa (OPK) Ultime notizie

pulisher
01:58 AM

Head to Head Review: OPKO Health (NASDAQ:OPK) vs. OptiNose (NASDAQ:OPTN) - Defense World

01:58 AM
pulisher
Oct 30, 2024

OPKO Health, Inc.'s (NASDAQ:OPK) CEO Phillip Frost is the most upbeat insider, and their holdings increased by 9.6% last week - Simply Wall St

Oct 30, 2024
pulisher
Oct 30, 2024

Here's Why You Should Retain OPKO Health Stock in Your Portfolio - MSN

Oct 30, 2024
pulisher
Oct 29, 2024

OPKO Health to Report Third Quarter 2024 Financial Results on November 7, 2024 - The Manila Times

Oct 29, 2024
pulisher
Oct 29, 2024

OPKO Health (NASDAQ:OPK) Trading 4.7% HigherShould You Buy? - MarketBeat

Oct 29, 2024
pulisher
Oct 29, 2024

SECONDARY HYPERPARATHYROIDISM MARKET TO WITNESS UPSURGE - openPR

Oct 29, 2024
pulisher
Oct 22, 2024

Us Prostate Cancer Instruments And Test Market Report: - openPR

Oct 22, 2024
pulisher
Oct 17, 2024

With 50% ownership, OPKO Health, Inc. (NASDAQ:OPK) insiders have a lot riding on the company's future - Yahoo Finance

Oct 17, 2024
pulisher
Oct 14, 2024

Hypopituitarism Market Forecasted to Surge in Coming Years, - openPR

Oct 14, 2024
pulisher
Oct 13, 2024

35,157 Shares in OPKO Health, Inc. (NASDAQ:OPK) Bought by Algert Global LLC - Defense World

Oct 13, 2024
pulisher
Oct 12, 2024

Renaissance Technologies LLC Cuts Stock Holdings in OPKO Health, Inc. (NASDAQ:OPK) - Defense World

Oct 12, 2024
pulisher
Oct 11, 2024

OPK Gets Additional BARDA Funding to Develop Multispecific Antibodies - MSN

Oct 11, 2024
pulisher
Oct 09, 2024

OPKO Health (NASDAQ:OPK) Stock Price Up 4.1%Time to Buy? - MarketBeat

Oct 09, 2024
pulisher
Oct 09, 2024

Squarepoint Ops LLC Invests $592,000 in OPKO Health, Inc. (NASDAQ:OPK) - MarketBeat

Oct 09, 2024
pulisher
Oct 08, 2024

Recent Analysts’ Ratings Updates for OPKO Health (OPK) - Defense World

Oct 08, 2024
pulisher
Oct 08, 2024

Hsbc Holdings PLC Sells 28,560 Shares of OPKO Health, Inc. (NASDAQ:OPK) - Defense World

Oct 08, 2024
pulisher
Oct 07, 2024

NextPlat expands OPKO e-commerce deal to Japan By Investing.com - Investing.com South Africa

Oct 07, 2024
pulisher
Oct 07, 2024

ModeX secures additional $35 million for antibody research By Investing.com - Investing.com South Africa

Oct 07, 2024
pulisher
Oct 07, 2024

Significant E-Commerce Expansions - Trend Hunter

Oct 07, 2024
pulisher
Oct 07, 2024

ModeX secures additional $35 million for antibody research - Investing.com

Oct 07, 2024
pulisher
Oct 07, 2024

NextPlat expands OPKO e-commerce deal to Japan - Investing.com India

Oct 07, 2024
pulisher
Oct 07, 2024

OPKO Health's (OPK) ModeX Therapeutics Secures $35M BARDA Supplement - StreetInsider.com

Oct 07, 2024
pulisher
Oct 07, 2024

ModeX Therapeutics Secures $35 Million BARDA Supplement to Develop COVID Multispecific Antibodies and $16 Million to Initiate Influenza Program - StockTitan

Oct 07, 2024
pulisher
Oct 02, 2024

OPKO Health (NASDAQ:OPK) Trading Up 5% - MarketBeat

Oct 02, 2024
pulisher
Oct 02, 2024

Labcorp’s $237.5 Million Acquisition of Assets of OPKO Health - Global Legal Chronicle

Oct 02, 2024
pulisher
Sep 30, 2024

Opko Health Inc’s: Contrasting Stock Performances in a Volatile Market - The InvestChronicle

Sep 30, 2024
pulisher
Sep 30, 2024

OPK’s price-to-free cash flow ratio: How it affects investment decisions - US Post News

Sep 30, 2024
pulisher
Sep 30, 2024

Upward Trajectory: Opko Health Inc (OPK) Posts a Gaine, Closing at 1.52 - The Dwinnex

Sep 30, 2024
pulisher
Sep 30, 2024

ENTX & OPK Stock May Gain Following Positive PK/PD Research Data - MSN

Sep 30, 2024
pulisher
Sep 26, 2024

Opko Health stock maintains Buy rating from H.C. Wainwright on positive data - Investing.com Canada

Sep 26, 2024
pulisher
Sep 26, 2024

OPKO Health's (OPK) Buy Rating Reaffirmed at HC Wainwright - MarketBeat

Sep 26, 2024
pulisher
Sep 26, 2024

OPKO Health (NASDAQ:OPK) Receives "Buy" Rating from HC Wainwright - MarketBeat

Sep 26, 2024
pulisher
Sep 26, 2024

Entera Bio and OPKO Health report promising obesity treatment study By Investing.com - Investing.com Australia

Sep 26, 2024
pulisher
Sep 25, 2024

Entera Bio and OPKO Health report promising obesity treatment study - Investing.com

Sep 25, 2024
pulisher
Sep 25, 2024

Entera Bio and OPKO Health Provide Update on PK/PD Results of Oral Oxyntomodulin (GLP-1/Glucagon) Peptide - EIN News

Sep 25, 2024
pulisher
Sep 24, 2024

OPKO Health (NASDAQ:OPK) Trading Down 2% - MarketBeat

Sep 24, 2024
pulisher
Sep 23, 2024

ModeX Therapeutics appoints new Chief Medical Officer By Investing.com - Investing.com Canada

Sep 23, 2024
pulisher
Sep 23, 2024

OPKO Health (NASDAQ:OPK) Shares Gap Down to $1.48 - MarketBeat

Sep 23, 2024
pulisher
Sep 23, 2024

OPKO Health’s ModeX Therapeutics Appoints Dr. Giovanni Abbadessa as Chief Medical Officer as Pipeline Advances into Clinical Development - XM

Sep 23, 2024
pulisher
Sep 23, 2024

ModeX Therapeutics appoints new Chief Medical Officer - Investing.com

Sep 23, 2024
pulisher
Sep 23, 2024

OPKO Health's (OPK) ModeX Therapeutics Appoints Dr. Giovanni Abbadessa as Chief Medical Officer as Pipeline Advances into Clinical Development - StreetInsider.com

Sep 23, 2024
pulisher
Sep 21, 2024

OPKO Health, Inc. (NASDAQ:OPK) Stake Boosted by Rubric Capital Management LP - MarketBeat

Sep 21, 2024
pulisher
Sep 20, 2024

OPKO Health (NASDAQ:OPK) Rating Reiterated by Barrington Research - MarketBeat

Sep 20, 2024
pulisher
Sep 20, 2024

Labcorp Stock Gains From Its Latest Acquisition of BioReference Health - MSN

Sep 20, 2024
pulisher
Sep 19, 2024

HC Wainwright Reiterates “Buy” Rating for OPKO Health (NASDAQ:OPK) - Defense World

Sep 19, 2024
pulisher
Sep 18, 2024

OPKO Health (NASDAQ:OPK) Stock Price Down 2.4% - MarketBeat

Sep 18, 2024
pulisher
Sep 18, 2024

OPKO Health (NASDAQ:OPK) Given Overweight Rating at Piper Sandler - Defense World

Sep 18, 2024
pulisher
Sep 18, 2024

Opko Health retains Buy rating from H.C. Wainwright post-asset sale - Investing.com Canada

Sep 18, 2024
pulisher
Sep 18, 2024

Piper Sandler maintains Overweight rating on Opko Health shares on strong prospects - Investing.com Canada

Sep 18, 2024
pulisher
Sep 17, 2024

Piper Sandler Reiterates Overweight Rating for OPKO Health (NASDAQ:OPK) - MarketBeat

Sep 17, 2024
pulisher
Sep 17, 2024

LabCorp slashes workforce in Melbourne after $237.5 million acquisition - The Business Journals

Sep 17, 2024
pulisher
Sep 17, 2024

OPKO Health (NASDAQ:OPK) Shares Gap Down to $1.64 - MarketBeat

Sep 17, 2024
$227.89
price down icon 1.94%
diagnostics_research LH
$230.56
price up icon 1.08%
diagnostics_research WAT
$326.59
price up icon 0.59%
$147.66
price up icon 1.14%
diagnostics_research MTD
$1,302.24
price up icon 0.39%
$451.08
price up icon 0.73%
Capitalizzazione:     |  Volume (24 ore):